SIGNAL TRANSDUCTION IN B CELL ACTIVATION
SIGNAL TRANSDUCTION IN B CELL ACTIVATION
批准号:
3132098
负责人:
John C Cambier
金额:
$21.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1984
资助国家:
美国
项目状态:
已结题
起止时间:
1984-12-01 至 1996-05-31
关键词:
B cell receptor B lymphocyte antireceptor antibody biological signal transduction calcium flux cytoskeleton hamsters immunoglobulins laboratory mouse laboratory rabbit leukocyte activation /transformation membrane proteins molecular cloning phosphoproteins phosphorylation protein structure function protein tyrosine kinase receptor expression tissue /cell culture transfection
中文摘要
B 淋巴细胞抗原受体、膜免疫球蛋白 (mIg) 的功能
跨质膜的信息传递导致改变
基因表达和细胞激活,以及聚焦和内化
抗原用于后续处理和呈递给 T 细胞。 最近
研究结果表明,在某些情况下,膜的结扎
免疫球蛋白也会导致细胞能力失活
未连接的受体来转导信号。 这种“脱敏”可能是
B 细胞库中克隆无能介导的耐受性基础。 的
所有这些功能的执行需要 mIg 分子
与细胞质中的分子进行物理交流。 这种蛋白质,或者
可能是间接的,涉及桥接的次级膜蛋白
受体 mIg 与胞质蛋白,或者可以是间接的,通过
mIg 的细胞质尾部与胞质蛋白的相互作用,或者可以
是间接的,涉及桥接受体的次级膜蛋白
mIg 至胞浆蛋白。 缺乏重要的细胞质结构
mIg 分子实际上排除了前一种可能性,直到
最近,只有零碎的数据支持后者
可能性。 我们发现膜免疫球蛋白是非共价的
与由两个二硫键组成的蛋白质复合物相关
异二聚体和这些复合物的成分之间略有不同
mIgM 相关和 mIgD 相关形式。 mIgM 与
IgMalpha (32kDa) 和 Igbeta (37kDa) 以及 IgMalpha 和 Igamma 的异二聚体
(34kDa) 蛋白质。 mIgD 与 IgDalpha 异二聚体相关
(33kDa)、Igbeta、IgDalpha 和 Igamma 蛋白。 最近的研究
表明 IgMalpha 和 IgDalpha 是 mb-1 基因的产物,并且
Igbeta 和 Igalpha 是 B29 基因的产物。 独特的阿尔法
亚基的使用可能决定了先前提到的生物学差异
mIgM 与 mIgD 连接后的反应。 与角色一致
信号转导和受体脱敏,多个亚基
上述复合物在酪氨酸残基上被诱导磷酸化。
在此应用中,我们建议确定这些蛋白质的功能
以及它们在介导受体中表现出的特定结构基序
功能。 这些研究将涉及 IgMalpha、IgDalpha、
Igbeta 和 Igamma 编码基因的蛋白质。 根据推导
序列,我们将生产针对复合物亚基的特异性抗体
并使用这些抗体来研究亚基分布和功能。 我们
将利用生化方法来识别特定位点
在信号转导、脱敏和
细胞骨架相互作用。 我们将确定具体的角色
通过产生和分析受体功能中的磷酸化事件
转染的 B 细胞表达突变受体亚基,其中特异性
磷酸化位点发生改变或缺失。 拟议的研究应该
为我们了解 B 的分子基础做出了重大贡献
淋巴细胞活化、抗原加工和耐受。
英文摘要
B lymphocyte antigen receptors, membrane immunoglobulins (mIg), function in
transduction of information across the plasma membrane leading to altered
gene expression and cell activation, and in focussing and internalization
of antigen for subsequent processing and presentation to T cells. Recent
findings indicate that under certain circumstances ligation of membrane
immunoglobulin also leads to inactivation of the ability of the cell's
unligated receptors to transduce signals. This "desensitization" may be
the basis of tolerance mediated by clonal anergy in the B cell pool. The
performance of all of these functions requires that mIg molecules
communicate physically with molecules in the cytoplasm. This protein, or
could be indirect, involving secondary membrane proteins which bridge
receptor mIg with cytosolic protein, or could be indirect, occurring via
interaction of the cytoplasmic tail of mIg with cytosolic protein, or could
be indirect, involving secondary membrane proteins which bridge receptor
mIg to cytosolic proteins. The lack of significant cytoplasmic structure
in mIg molecules virtually excludes the former possibility and, until
recently, only fragmentary data existed in support of the latter
possibility. We have found that membrane immunoglobulins are noncovalently
associated with a complex of proteins composed of two disulfide bonded
heterodimers and that components of these complexes differ slightly between
mIgM-associated and mIgD-associated forms. mIgM is associated with
heterodimers of IgMalpha(32kDa) and Igbeta(37kDa), and IgMalpha and Iggamma
(34kDa) proteins. mIgD is associated with heterodimers of IgDalpha
(33kDa), and Igbeta, and IgDalpha and Iggamma proteins. Recent studies
indicate that IgMalpha and IgDalpha are products of the mb-1 gene(s), and
that Igbeta and Igalpha are products of the B29 gene(s). Distinct alpha
subunit usage may determine the previously noted differences in biological
responses which follow mIgM vs. mIgD ligation. Consistent with a role in
signal transduction and receptor desensitization, multiple subunits of the
above complex are inducibly phosphorylated on tyrosine residues.
In this application, we propose to determine the function of these proteins
and specific structural motifs which they exhibit, in mediating receptor
function. These studies will involve the cloning of IgMalpha, IgDalpha,
Igbeta and Iggamma encoding proteins of the genes. Based on deduced
sequence, we will produce antibodies specific for subunits of the complex
and use these antibodies to study subunit distribution and function. We
will utilize biochemical approaches to identify specific sites
phosphorylated during signal transduction, desensitization, and
cytoskeletal interaction. We will determine the role of specific
phosphorylation events in receptor function by production and analysis of
transfected B cell which express mutant receptor subunits in which specific
phosphorylation sites are altered or absent. The proposed studies should
contribute significantly to our understanding of the molecular basis of B
lymphocyte activation, antigen processing and tolerance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Autoimmunity risk alleles compromising B cell anergy
-
批准号:9568080
-
项目类别:
-
资助金额:$11.26万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Autoimmunity risk alleles compromising B cell anergy
-
批准号:9121221
-
项目类别:
-
资助金额:$45.51万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Insulin Specific T and B cells in Type 1 Diabetes
-
批准号:9180031
-
项目类别:
-
资助金额:$168.89万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Perturbation of B cell anergy in T1D
-
批准号:9225164
-
项目类别:
-
资助金额:$19.44万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
Perturbation of B cell anergy in T1D
-
批准号:9121223
-
项目类别:
-
资助金额:$23.33万
-
财政年份:2016
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8372067
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:9104150
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8690052
-
项目类别:
-
资助金额:$32.51万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Mouse modeling of a human STING gene variant for infectious disease
-
批准号:8282484
-
项目类别:
-
资助金额:$19.26万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Mouse modeling of a human STING gene variant for infectious disease
-
批准号:8519291
-
项目类别:
-
资助金额:$21.79万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
B Cells and Type 1 Diabetes
-
批准号:8534115
-
项目类别:
-
资助金额:$31.37万
-
财政年份:2012
-
负责人:John C Cambier
-
依托单位:
Flow Cytometry
-
批准号:8311794
-
项目类别:
-
资助金额:$11.73万
-
财政年份:2011
-
负责人:John C Cambier
-
依托单位:
Maintenance of B Cell Anergy
-
批准号:8311792
-
项目类别:
-
资助金额:$31.85万
-
财政年份:2011
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:7893587
-
项目类别:
-
资助金额:$21.65万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
B Cell Development in Aging
-
批准号:7879507
-
项目类别:
-
资助金额:$18.93万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Infectious Agents and B Cell Anergy
-
批准号:8188300
-
项目类别:
-
资助金额:$37.87万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:8468627
-
项目类别:
-
资助金额:$22.53万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Infectious Agents and B Cell Anergy
-
批准号:8580189
-
项目类别:
-
资助金额:$37.87万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:9804163
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
Molecular Mechanisms of Immune Tolerance
-
批准号:8055949
-
项目类别:
-
资助金额:$21.4万
-
财政年份:2009
-
负责人:John C Cambier
-
依托单位:
海外基金